[Possibilities in the evaluation of therapeutic effects in idiopathic pulmonary hemosiderosis].
D006486:Hemosiderosis / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007408:Intestinal Absorption; D007501:Iron / Q000378:metabolism; D008171:Lung Diseases / Q000188:drug therapy* / Q000378:metabolism; D011241:Prednisone / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D007501:Iron; D011241:Prednisone
Uber Möglichkeiten zur Beurteilung der Behandlungseffektivität bei idiopathischer Lungenhämosiderose.